Cernostics Appoints Dr. John Inadomi as Scientific Adviser

Cernostics, Pittsburgh and Danville, Penn.-based molecular diagnostics company, has announced John M. Inadomi, MD, will serve as a scientific adviser.

Advertisement


Sign up for our FREE GI E-Weekly for more coverage like this sent to your inbox!

In this capacity Dr. Inadomi will help Cernostics develop tests to identify a patient’s risk of Barrett’s Esophagus and gastroesophageal reflux disease.

He currently serves as the division chief of gastroenterology and Cyrus E. Rubin Professor of Medicine at the University of Washington in Seattle.

More Articles on Gastroenterology:
3 Statistics on Colonoscopy Procedure Times in ASCs
New York Medical Society Re-Elects Dr. Jerome Cohen as Speaker
Orange County’s Digestive Disease Center, MemorialCare Medical Foundation Form Partnership

At the Becker’s 32nd Annual Meeting: The Business and Operations of ASCs, taking place October 29-31 in Chicago, ASC leaders, surgeons and healthcare executives will explore strategies to drive growth, enhance operational performance, navigate reimbursement challenges and prepare for the future of ambulatory surgery. Apply for complimentary registration now.

Advertisement

Next Up in GI & Endoscopy

Advertisement

Comments are closed.